Why the study?
It was unknown to what extent sildenafil modulates systemic redox status and cerebrovascular function during acute hypoxia exposure.
Does sildenafil improve systemic redox status and cerebrovascular function in healthy males exposed to acute hypoxia?
Does sildenafil improve systemic redox status and cerebrovascular function in healthy males exposed to acute hypoxia?
Sildenafil enhances select aspects of cerebrovascular function during acute hypoxia by improving systemic redox homeostasis, independent of altered vascular nitric oxide bioavailability.
Sildenafil may alter redox and cerebrovascular responses in acute hypoxia; extends PDE5 inhibition data but leaves clinical translation open.
To what extent sildenafil, a selective inhibitor of the type-5 phosphodiesterase modulates systemic redox status and cerebrovascular function during acute exposure to hypoxia remains unknown. To address this, 12 healthy males (aged 24 ± 3 y) participated in a randomized, placebo-controlled crossover study involving exposure to both normoxia and acute (60 min) hypoxia (Fi O 2 = 0.14), followed by oral administration of 50 mg sildenafil and placebo (double-blinded). Venous blood was sampled for the ascorbate radical (A •− : electron paramagnetic resonance spectroscopy) and nitric oxide metabolites (NO: ozone-based chemiluminescence). Transcranial Doppler ultrasound was employed to determine middle cerebral artery velocity (MCAv), cerebral delivery of oxygen (CDO 2 ), dynamic cerebral autoregulation (dCA) and cerebrovascular reactivity to hypo/hypercapnia (CVR CO2HYPO/HYPER ). Cortical oxyhemoglobin (cO 2 Hb) and oxygenation index (OI) were assessed using pulsed continuous wave near infra-red spectroscopy. Hypoxia decreased total plasma NO ( P = 0.008), CDO 2 ( P = <0.001) and cO 2 Hb ( P = 0.005). In hypoxia, sildenafil selectively reduced A •− ( P = 0.018) and MCA V ( P = 0.018), and increased dCA metrics of low-frequency phase ( P = 0.029) and CVR CO2HYPER ( P = 0.007) compared to hypoxia-placebo. Collectively, these findings provide evidence for a PDE-5 inhibitory pathway that enhances select aspects of cerebrovascular function in hypoxia subsequent to a systemic improvement in redox homeostasis and independent of altered vascular NO bioavailability.
No takes yet. Share an insight, caveat, or question.
Stacey et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: